Food and Drug Law Journal Symposium
Going Viral: Safeguarding Public Health in the Modern Era

One of the fundamental responsibilities of government is protecting the public health. While food and drug law-related issues have faced public pressure since the inception of regulation, the speed and breadth of information sharing has transformed the role. Today, a single scientific study, news article, or individual on the Internet can start a movement and quickly sway public opinion—even if it’s spreading misinformation. Intense pressure from the public may prompt legislatures or administrative agencies to craft laws, rules, regulations, policies, or casual Agency actions to address these concerns. This academic symposium will explore the public health impacts when these actions are based not on exhaustive scientific studies, but on public pressure. Examples might include legislation and regulations related to stem cells and regenerative medicine, the “right to try,” vaccines, opioids, compounding by outsourcing facilities, direct-to-consumer pricing, and genetically modified organisms.

Call for Abstracts

The Call for Abstracts is now open and will close on August 2, 2019. Accepted articles will be notified by August 16, and draft articles must be submitted by November 1.

Please contact Paige Samson with any questions.

Submit

Register Now

Industry & Firms

FREE
  • $199 for nonmembers

Non-Profit

FREE
  • $49 for nonmembers

Government

FREE
  • $49 for nonmembers

Academic

FREE
  • $49 for nonmembers

Student

FREE
  • full-time students only
Coming Soon

Planning Committee

  • Anthony J. Anscombe, Steptoe & Johnson LLP
  • Nigel Barrella, Law Office of Nigel Barrella
  • Kenita Barrow, Otsuka America Pharmaceutical, Inc.
  • Laurie J. Beyranevand, Vermont Law School
  • Barbara A. Binzak Blumenfeld, Buchanan Ingersoll & Rooney PC (Chair)
  • Marie Boyd, University of South Carolina
  • Nathan Brown, Akin Gump Strauss Hauer & Feld LLP
  • Catherine A. Clements, Eli Lilly and Company
  • Carl Fischer, Becton Dickinson
  • Ralph Hall, University of Minnesota
  • Peter Barton Hutt, Covington & Burling LLP
  • Erica Michele Jackson, K&L Gates LLP
  • William M. Janssen, Charleston School of Law
  • John Johnson, FDAImports.com, LLC/ Benjamin L. England & Associates LLC
  • Alan C. Katz, toXcel, LLC
  • Sari Bourne Kaplan, Genentech, Inc.
  • Sara Wexler Koblitz, Hyman, Phelps & McNamara, PC
  • Hilary Lewis, Morgan, Lewis & Bockius LLP
  • Priya Malavika Mannan, Novartis Pharmaceuticals Corporation
  • Alexandra Marzelli, FDA – OC
  • J.R. McNair, Winston & Strawn LLP
  • Alan Minsk, Arnall Golden Gregory, LLP
  • Nicole E. Negowetti, Harvard Law School
  • James T. O’Reilly, University of Cincinnati
  • Bruce Patsner, University of Houston
  • Sandra Retzky, FDA – CTP
  • Jessica Ringel, King & Spalding LLP
  • Melissa B. Runsten, Debevoise & Plimpton, LLP
  • Marc Scheineson, Alston & Bird LLP
  • Jodi Schipper, FDA – CDER
  • Shy Shorer, National Institutes of Health
  • David C. Spangler, Consumer Healthcare Products Association (CHPA)
  • Andrew Wasson, Haug Partners LLP
  • Emily Wright, Pfizer, Inc.
  • Lowell Zeta, Hogan Lovells US LLP
  • Patricia Zettler, Georgia State University

Continuing Legal Education

FDLI applies for CLE credits in Ohio, Pennsylvania, and Virginia. These CLE approvals may also be honored by other states; please check with your bar association for guidance. The CLE credits will be posted as they are granted and you can request to be notified when approval is received.

 

Location and Overnight Accommodations

Location

Location will be announced soon.

Overnight Accommodations

Accommodation options will be announced soon.

 

Please contact the Conference Department with any accessibility requirements or dietary restrictions, or for other questions.